Imorgon
Improve radiology reporting efficiency and report quality with Imorgon's reporting automation.
As the top DICOM SR software for radiology, our solution significantly reduces unnecessary dictation by precisely transferring ultrasound and DEXA modality measurements into Powerscribe, Fluency, or RadAI. This eliminates manual errors and significantly accelerates the generation of reports.
Imorgon's unique advantages include:
- guaranteed transfer of all measurements - usually DICOM SR
- electronic worksheets for direct report population (eliminating dictation from notes)
- worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- integration with Epic and other EHRs.
- vendor-neutral
Our dedicated support team ensures uninterrupted workflow.
Invest in Imorgon for a quick and substantial return on investment, transforming your reporting overhead into a streamlined, high-quality operation.
Learn more
RXNT
RXNT's cloud-based, ambulatory healthcare software empowers medical practices and healthcare organizations of all sizes and most specialties to launch, succeed, and scale through innovative, data-backed, AI-powered software.
Our integrated, ONC-certified healthcare software system—including Electronic Health Records, Practice Management, Medical Billing and RCM, E-Prescribing, Practice Scheduling, Patient Portal, and more—will streamline clinical outcomes, practice management, and revenue cycle management for your medical organization.
RXNT is trusted by over 60 thousand providers and medical professionals across all 50 states in the U.S.A. to drive business growth, optimize operations, and improve the quality of patient care.
All of our SaaS-based software products can be purchased standalone, but you can run you entire practice—from encounter to billing—with our unified Full Suite system. It utilizes a secure, central database so your data passes through every product in real-time from anywhere. Using our software, more than 125MM prescriptions have been transmitted and over $7B in claims have been processed.
Our predictable, transparent subscription pricing model includes free setup & training, support, mobile apps, and more.
Learn more
Elements Contrast Clearance Analysis
Brainlab's Elements Contrast Clearance Analysis is an MRI-based technique aimed at distinguishing areas of contrast clearance and accumulation within brain tumor imaging datasets. This advanced high-resolution analysis enhances the understanding required for ongoing evaluations and decision-making across various clinical fields, including radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The methodology entails capturing two standard 3D T1-weighted MRIs; the first scan is taken around 5 minutes after administering a standard dose of contrast agent, while the second scan occurs 60 to 105 minutes later. By subtracting the initial series from the subsequent one, volumetric maps are created that clearly identify zones of contrast clearance (shown in blue) against those of contrast accumulation (illustrated in red). These findings empower clinicians to better evaluate the effects of radiation treatment in contrast to potential tumor regrowth, allowing for more educated decisions regarding both initial and subsequent treatment plans. As a result, this analysis not only aids in clinical assessments but also enhances the overall management of patient care in complex cases.
Learn more
Tempus
Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.
Learn more